JosephTauberMD

Ophthalmology • Kansas City, MO

Cornea & External Disease, Refractive Surgery, Retinal Disease, Uveitis

Owner, Tauber Eye Center

Join to view full profile

Dr. Tauber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tauber's full profile

Already have an account?

Office
4400 Broadway Blvd
Ste 202
Kansas City, MO 64111
Phone+1 816-531-9100

Fax+1 816-531-9105

Summary

Dr. Joseph Tauber is an ophthalmologist in Kansas City, MO. He specializes in cornea & external disease, refractive surgery and uveitis and is experienced in sjogren's syndrome, cataract surgery, corneal transplant surgery. He is also Chief Medical Officer for Brightstar Therapeutics and of Vital Tears.

Education & Training

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 1988 - 1989
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1987 - 1989
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 1987 - 1988
Tufts Medical CenterResidency, Ophthalmology, 1984 - 1987
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1983 - 1984
Northwestern Medical Center1982 - 1983
Harvard Medical SchoolClass of 1982
Union CollegeBS, Biology and Chemistry, Summa Cum Laude, 1978

Certifications & Licensure

KS State Medical License 1997 - 2025
MO State Medical License 1989 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Member, Cornea Subcommittee American Academy of Ophthalmology Program Committee 2002-2006, 2006
American Academy of Ophthalmology Achievement Award 2005
National Eye Institute Individual NRSA Award (EY06052) Massachusetts Eye & Ear Infirmary, 1987-1989, 1989
Heed Foundation/Knapp Fellowship Massachusetts Eye & Ear Infirmary, 1988, 1989
Heed Ophthalmic Foundation Fellowship Massachusetts Eye & Ear Infirmary, 1987, 1988
William E. Lasnik Prize Union College
Founding Member Cabot Medical Society Harvard Medical School
Co-chairman House Staff Committee Northwestern Memorial Hospital
Charles J. Preefer Resident Research Award Tufts-New England Medical Center
Super Doctor SuperDoctors.com
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Dry Eye Assessment and Management Study Start of enrollment: 2014 Nov 01
Completed
Phase 3
Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation Start of enrollment: 2014 May 01
Completed
Phase 3
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Start of enrollment: 2014 Jul 01
Completed
Phase 2
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01
Completed
Phase 3
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease Start of enrollment: 2021 Jan 11
Completed
Phase 2
Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease Start of enrollment: 2021 Jan 07
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

776 citations
TFOS DEWS II Management and Therapy Report
Lyndon Jones, Laura E Downie, Donald R. Korb, Jose M. Benitez-del-Castillo, Reza Dana
The Ocular Surface. 2017-07-01
427 citations
Tear osmolarity in the diagnosis and management of dry eye disease
Michael A. Lemp, Anthony J. Bron, Christophe Baudouin, Jose M. Benitez del Castillo, David Geffen
American Journal of Ophthalmology. 2011-05-01
76 citations
Improved detection of disease progression in ocular cicatricial pemphigoid.
Joseph Tauber, N Jabbur, Christopher S. Foster
Cornea. 1992-09-01

Journal Articles

Evaluation of Two Different Methods of Epithelial Removal Prior to Excimer Laser Photorefractive Keratectomy for Myopia.
Tauber J, Cable M, Chavala S, Polepalle S, Investigative Ophthalmology Visual Science 40 (4): S107
Two Zone PRK for Moderate Myopia.
Piebenga LW, Matta CS, Deitz MR, Tauber J, Ophthalmology 100 (9A): 108
A Multicenter Comparison of Diclofenac Sodium 0.1% (DS) to Ketorolac Tromethamine 0.5% (KT) in Patients with Acute Seasonal Allergic Conjunctivitis (SAC).
Tauber J, et. al, Investigative Ophthalmology Visual Science 35 (4): 1291
Changes in Corneal Topography After Instillation of Artificial Lubricants.
Yu JS, Wu M, Crosser V, Tauber J, Investigative Ophthalmology Visual Science 35 (4): 1291
Contact Lens and Spectacle Use Before and After PRK.
Jaffe MR, Ranjan MR, Tauber J, CLAO 20 (Suppl): 48
Two Zone Excimer Photorefractive Keratectomy for Moderate Myopia. 6 to 18 Month Follow-up.
Piebenga LW, Matta CS, Deitz MR, Tauber J, Ophthalmology 102: 1054-1059
Duration of Tear Osmolarity Changes Following Instillation of Artificial Lubricants In Patients With Keratoconjunctivitis Sicca.
Crosser V, Mardelli P, Wu A, Tauber J, Investigative Ophthalmology and Visual Science 36: S998
The Effects of Instillation of Topical NSAIDs on Corneal Sensation.
Tauber J, Garner L, Niknia H, Crosser V, Investigative Ophthalmology and Visual Science 36: S576
Temporary Intracanalicular Collagen Implants In Normal Volunteers.
Tauber J, Garner L, Rioux N, Investigative Ophthalmology and Visual Science 37: S853
Epidemiological Study of Punctal Size in Normal Volunteers.
Rioux N, Garner L, Tauber J, Investigative Ophthalmology and Visual Science 37: S566
Photorefractive Keratectomy Results as a function of Preoperative Astigmatism.
Garner L, Crosser V, Tauber J, Investigative Ophthalmology and Visual Science 37: S566
Five and Three Year Follow-up of Photorefractive Keratectomy for Myopia of –1 to –6 Diopters.
Matta CS, Piebenga LW, Deitz MR, Tauber J, Garner L, Journal of Refractive Surgery 14:318-324
Excimer Retreatment for Myopic Photorefractive Keratectomy Failures. Six to 18 Month Follow-up.
Matta CS, Piebenga LW, Deitz MR, Tauber J, Ophthalmology 103: 444-451
Ablation Zone Centration after Photorefractiuve Keratectomy and Its Effect on Visual Outcome.
Deitz MR, Piebenga LW, Matta CS, Tauber J, Anello RD, DeLuca M, Journal of Cataract and Refractive Surgery 22(6): 696-701
The Effects of Instillation of Diclofenac sodium 0.1% on Photophobia following Pupillary Dilation. A Pilot Study in Normal Volunteers.
Tauber J, Raphtis C, Investigative Ophthalmology Visual Science 38 (4): S142
A Multicenter Comparison of the Ocular Efficacy and Safety of Diclofenac 0.1% Solution with that Of Ketoralac Tromethamine 0.5% Solution in Patients with Acute Seasona...
Tauber J, Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Gill, D, Schaich L, Journal of Ocular Pharmacology and Therapeutics 14 (2): 137-146
Excimer Photorefractive Keratectomy for Myopia.
Piebenga LW, Deitz MR, Matta CS, Tauber J, Irvine JW, Sabates FN, Ophthalmology 100 (9): 1335-1345
Refractive Outcomes Following Excimer Laser Photorefractive Keratectomy for Myopia Using Two Different VISX Excimer Lasers.
Cable M, Matta C, Piebenga L, Polepalle S, Steward C, Tauber J, Investigative Ophthalmology Visual Science 40 (4): S106
Safety and Efficacy of Nedocromil Sodium Ophthalmic Solution 25 BID in Patients with Ocular Itch Associated With Allergic Conjunctivitis.
Tauber J, Alocril Community Ocular Allergy Trial Study Group, Investigative Ophthalmology Visual Science 42(4) S910
Efficacy and Safety of Combination Therapy with Brimonidine 0.2% and Latanoprost 0.005% Versus Fixed Combination Timolol 0.5%/Dorzolamide 2%
Zabriskie N A, Ahmed I K, Cantor L B, Kent A B, Mundorf T, Tauber J, Rubin J M, Hoop J, Investigative Ophthalmology Visual Science 42 (4) S833
Phase 2 Dose Ranging Efficacy Trial of INS365 Ophthalmic Solution, A P2Y2 Agonist, in Patients with Dry Eye.
Foulks G, Sall K, Greenberg M, Tauber J, Donshik P, Berdy G, Sylvester R, Yerxa B, Crockett S, Kellerman D, Investigative Ophthalmology Visual Science 42 (4) S713
Nedocromil Sodium Ophthalmic Solution 2% Twice Daily in Patients with Allergic Conjunctivitis.
Tauber J, and the Alocril Community Allergy Trial Study Group, Advances in Therapy 19 (2) 73-84
Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafasol Tetrasodium (INS365) Ophthalmic Solution for the Treatment of Dry Eye.
Tauber J, Kellerman D, Cornea 23 (8) 784-792
Phase III Safety Evaluation of Cyclosporine 0.1% Ophthalmic Emulsion Administered Twice Daily to Dry Eye Disease Patients for Up to 3 Years.
Barber LD, Pflugfelder SC, Tauber J, Foulks GN, Ophthalmology 112: 1790-1794
Wegener’s Granulomatosis.
Choopong P, Tauber J, Foster CS, Contemporary Ophthalmology
Join now to see all

Books/Book Chapters

Ocular Circulation and Neovascularization.
Chapter: Cryotherapy for Iris Neovascularization and Neovascular glaucoma (Series 50)
Page 383 - 386Lahav M, Tauber J, Haug SEditors: D BenEzra, SJ Ryan, BM Glaser And RP Murphy.Martinus Nijhoff/DR W Junk Publishers
Diseases of the Eye and Skin.
Chapter: Cicatricial Pemphigoid
Tauber J, Foster CSEditors: Mannis MJ, Macsai MS, Huntley AC.Raven Press, New York, NY
Diseases of the Eye and Skin.
Chapter: Wegener’s Granulomatosis
Tauber J, Hall JCEditors: Mannis MJ, Macsai MS, Huntley AC.Raven Press, New York, NY
Cornea.
Chapter: Juvenile Rheumatoid Arthritis
Tauber JEditors: Krachmer JH, Mannis MJ, Holland EJ.CV Mosby, St. Louis
The Cornea.
Chapter: Parasitic Keratitis and Conjunctivitis
Page 427 - 446Tauber J, Jehan FEditors: Foster CS, Azar DT, Dohlman CH.Lippincott Williams & Wilkins, PhiladelphiaEdition 4,
Cornea.
Chapter: Juvenile Rheumatoid Arthritis
Tauber JEditors: Krachmer JH, Mannis MJ, Holland EJ.CV Mosby, St. LouisEdition 2,
Curbside Consultation in Cornea and External Disease.
Chapter: Followup of Penetrating Keratoplasty
Tauber JEditors: Price.Slack, Thoroughfare NJ
Intraocular Inflammation.
Chapter: Amebiasis
Tauber JEditors: Zierhut, M, Ohno S, Orefice F, Pavesio C, Rao N.Springer-Verlag, Heidelberg
Intraocular Inflammation.
Chapter: Giardiasis
Tauber JEditors: Zierhut, M, Ohno S, Orefice F, Pavesio C, Rao N.Springer-Verlag, Heidelberg
Cornea.
Chapter: Juvenile Idiopathic Arthritis
Tauber JEditors: Krachmer JH, Mannis MJ, Holland EJ.CV Mosby, St. LouisEdition 3,
Curbside Consultation in Uveitis: 49 Clinical Questions.
Chapter: Is There a Difference Between the Various Corticosteroid Preparations?
Page 41 - 44Tauber JEditors: Foster CS.Slack, Thoroughfare NJ
Join now to see all

Authored Content

Myths and Misconceptions About Autologous Serum for Dry EyeJune 2020

Press Mentions

$Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting$
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual MeetingApril 25th, 2022
VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye DiseaseMarch 23rd, 2022
Chutes & Ladders—Novartis Loses 2 Leaders, One to MiroBio, Another to a Video Game CompanySeptember 24th, 2021
Join now to see all

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow